Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma - results of the UK HD3 relapse treatment strategy
Authors:
- 7 February 2014
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 165 (4) , 534-544
Abstract
The purpose of this national retrospective study was to evaluate the outcome in children with relapsed or primary refractory Hodgkin lymphoma [HL] after a primary chemotherapy alone treatment strategy. Between 2000 and 2005, 80 children with relapsed [n = 69] or primary refractory [n = 11] HL were treated on a standardized treatment protocol of 4-6 cycles of EPIC [etoposide, prednisolone, ifosfamide and cisplatin] chemotherapy. Radiotherapy was recommended to all relapsed sites. High dose therapy with stem cell rescue [SCT] was recommended for patients with poor response. The 5-year overall survival [OS] and progression-free survival from relapse was 75·8% [64·8-83·9] and 59·9% [48·3-69·7] respectively. Duration of first remission was strongly associated with OS; risk of death was decreased by 53% [Hazard ratio (HR): 0·47, 95% confidence interval (CI): 0·19-1·18] for those with a time from end of treatment to relapse of 3-12 months (compared to 12 months after end of treatment. Other poor prognostic factors included advanced stage disease at relapse and B symptoms at first diagnosis. The most important factor associated with salvage failure was time to relapse. Survival outcome in children with primary refractory HL is poor.Keywords
This publication has 33 references indexed in Scilit:
- Targeted therapy in relapsed classical hodgkin lymphoma.Journal of the National Comprehensive Cancer Network, 2013
- Treatment of Children and Adolescents With Hodgkin Lymphoma Without Radiotherapy for Patients in Complete Remission After Chemotherapy: Final Results of the Multinational Trial GPOH-HD95Journal of Clinical Oncology, 2013
- Current treatment strategies in Hodgkin lymphomasCurrent Opinion in Oncology, 2012
- ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATIONMediterranean Journal of Hematology and Infectious Diseases, 2012
- Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor StudyBlood, 2011
- Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescentsBritish Journal of Haematology, 2010
- Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphomaBone Marrow Transplantation, 2008
- Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patientsBone Marrow Transplantation, 2007
- Does bulky disease at diagnosis influence outcome in childhood Hodgkin’s disease and require higher radiation doses? Results from the German–Austrian Pediatric Multicenter Trial DAL-HD-90International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Autologous Hematopoietic Stem-Cell Transplantation for Relapsed or Refractory Hodgkin's Disease in Children and AdolescentsJournal of Clinical Oncology, 1999